Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

- Distinguished vascular surgeon brings decades of clinical experience, innovation, and leadership to new role at cutting-edge biotech manufacturer -

- Appointment brings important surgical experience and perspective to Humacyte’s corporate leadership team as clinical adoption of Symvess ramps up and pipeline indications move toward planned approval -

DURHAM, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that Todd E. Rasmussen, M.D., has joined the company as Chief Surgical Officer.

In this role, Dr. Rasmussen will focus on providing peer-to-peer scientific support, medical education, and technical insights to surgeons and other healthcare providers. He will bring an experienced surgical perspective and leadership to the development of education and clinical support materials aligned with regulatory guidance to optimize the safe, appropriate, and effective implantation of Humacyte products.

“The most meaningful advances in surgery occur when clinicians, scientists, and engineers work together to translate new innovations to the operating room and to the patient’s bedside. I’ve had the privilege of working alongside the team at Humacyte for more than a decade as they created and made available a pioneering, off-the-shelf biologic conduit. I look forward to building on that shared experience and my own as a surgeon to support U.S. and international colleagues in the safe and effective integration of this and similar technologies into clinical practice,” said Dr. Rasmussen.

Dr. Rasmussen joins Humacyte with extensive expertise as a vascular surgeon, having completed a 28-year career in the U.S. Air Force during which he deployed multiple times during the Iraq and Afghanistan Wars and led major medical research programs for the Department of Defense. Following his retirement from military service, he joined Mayo Clinic as Professor of Surgery and Consultant in Vascular and Endovascular Surgery. Dr. Rasmussen will continue his clinical, educational, and administrative responsibilities at Mayo Clinic while serving separately as Chief Surgical Officer at Humacyte.

Schreibe Deinen Kommentar